Glucocerebrosidase-IN-1
Modify Date: 2024-04-03 18:09:16
Glucocerebrosidase-IN-1 structure
|
Common Name | Glucocerebrosidase-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 2279945-76-3 | Molecular Weight | 245.36 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H27NO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Glucocerebrosidase-IN-1Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC50 of 29.3 μM and a Ki of 18.5 μM. Glucocerebrosidase-IN-1 can be used for the research of Gaucher disease (GD) and Parkinson’s disease (PD)[1]. |
| Name | Glucocerebrosidase-IN-1 |
|---|
| Description | Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC50 of 29.3 μM and a Ki of 18.5 μM. Glucocerebrosidase-IN-1 can be used for the research of Gaucher disease (GD) and Parkinson’s disease (PD)[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 29.3 ± 1.8 μM (Glucocerebrosidase)[1] |
| In Vitro | Glucocerebrosidase-IN-1 (compound 11a) is able to enhance GCase activity 1.8-fold in fibroblasts bearing the homozygous L444P mutation[1]. |
| References |
| Molecular Formula | C13H27NO3 |
|---|---|
| Molecular Weight | 245.36 |